| LeukoStrat CDx FLT3 Mutation Assay (P160040/S013) | Invivoscribe Technologies, Inc. | 2024-09-27 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S011) | Invivoscribe Technologies, Inc. | 2023-07-20 |
| LeukoStrat® CDx FL T3 Mutation Assay (P160040/S012) | Invivoscribe Technologies, Inc. | 2023-02-06 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S010) | Invivoscribe Technologies, Inc. | 2022-04-11 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S007) | Invivoscribe Technologies, Inc. | 2021-08-26 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S009) | Invivoscribe Technologies, Inc. | 2021-08-11 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S008) | Invivoscribe Technologies, Inc. | 2021-08-05 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S006) | Invivoscribe Technologies, Inc. | 2020-05-14 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S004) | Invivoscribe Technologies, Inc. | 2018-12-21 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S003) | Invivoscribe Technologies, Inc. | 2018-12-07 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S002) | Invivoscribe Technologies, Inc. | 2018-11-28 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040/S001) | Invivoscribe Technologies, Inc. | 2018-01-19 |
| LeukoStrat CDx FLT3 Mutation Assay (P160040) | Invivoscribe Technologies, Inc. | 2017-04-28 |